Literature DB >> 18477169

Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.

Siak-Kim Tan, Chee-Seng Sim, Chee-Leok Goh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477169     DOI: 10.1111/j.1365-4632.2008.03448.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  6 in total

1.  Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site.

Authors:  Wen Chun Liu; Hong Liang Tey; Joyce Siong See Lee; Boon Kee Goh
Journal:  Singapore Med J       Date:  2014-01       Impact factor: 1.858

2.  Pigmented colloid milium associated with exogenous ochronosis in a farmer with long-term exposure to fertilizers.

Authors:  Maryam Akhyani; Parvaneh Hatami; Zahra Yadegarfar; Alireza Ghanadan
Journal:  J Dermatol Case Rep       Date:  2015-06-30

3.  Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of Polypodium Leucotomos Extract in the Treatment of Melasma in Asian Skin: A Pilot Study.

Authors:  Chee-Leok Goh; Sai Yee Chuah; Steven Tien; Guan Thng; María Alejandra Vitale; Arancha Delgado-Rubin
Journal:  J Clin Aesthet Dermatol       Date:  2018-03-01

4.  Exogenous ochronosis After Prolonged Use of Topical Hydroquinone (2%) in a 50-Year-Old Indian Female.

Authors:  Vijay Gandhi; Prashant Verma; Geetanjali Naik
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

Review 5.  Current Knowledge on Microviridin from Cyanobacteria.

Authors:  Samuel Cavalcante do Amaral; Patrick Romano Monteiro; Joaquim da Silva Pinto Neto; Gustavo Marques Serra; Evonnildo Costa Gonçalves; Luciana Pereira Xavier; Agenor Valadares Santos
Journal:  Mar Drugs       Date:  2021-01-04       Impact factor: 5.118

Review 6.  Efficacy and Safety of Oral Herbal Drugs Used as Adjunctive Therapy for Melasma: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Qingti Tang; Hongjie Yang; Xiarong Liu; Yu Zou; Xintong Lv; Kai Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-06       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.